Flow Medical develops an integrated, steerable catheter system for interventional pulmonary embolism treatment. This all-in-one device streamlines procedures by combining angiography, infusion, and monitoring capabilities. The system provides real-time feedback to precisely track clot resolution, optimizing lytic delivery and improving patient outcomes.
Funding
$5.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
UMFounders
Product
Problem
Pulmonary embolism (PE) is a major public health problem, causing significant mortality and healthcare costs due to blood clots obstructing blood flow in the lungs. Current catheter-directed thrombolysis (CDT) treatments lack real-time feedback, leading to imprecise medication delivery and complications such as bleeding or long-term pulmonary hypertension. The inability to precisely monitor clot resolution contributes to high readmission rates following CDT procedures.
Solution
Flow Medical is developing a steerable, all-in-one catheter system designed to enhance catheter-directed thrombolysis for pulmonary embolism treatment. The device integrates angiography, infusion, and real-time monitoring capabilities, enabling physicians to track clot resolution during the procedure. This integrated feedback mechanism allows for optimized medication delivery, ensuring the right amount of lytic is administered at the right time. By providing real-time data on clot dissolution, the system aims to reduce complications associated with imprecise treatment and improve patient outcomes. The user-centered design streamlines procedures and reduces inventory needs.
Target Audience
The primary target audience includes interventional radiologists and cardiologists specializing in pulmonary embolism treatment, as well as hospitals and medical centers performing catheter-directed thrombolysis procedures.
Features
- Steerable catheter with integrated angiography, infusion, and monitoring capabilities
- Real-time clot resolution tracking to guide medication delivery
- Data-driven feedback mechanism for optimized lytic administration
- User-centered design developed by leading interventional radiologists and cardiologists
- Streamlined procedures to improve lytic delivery
- Reduced inventory needs with an all-in-one system